NCT04657822 Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study Status RECRUITING Phase PHASE4
NCT04629430 Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT Status COMPLETED Phase NA
NCT04628585 Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy Status ENROLLING_BY_INVITATION Phase N/A
NCT04624659 A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04614610 Lidocaine Intravenous in the Emergency Department For Sickle Cell Crisis Status UNKNOWN Phase PHASE2
NCT04610866 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04606160 Utilizing A Single Session Problem-Solving Intervention With Caregivers of Pediatric Patients Receiving Chronic Transfusion to Treat Sickle Cell Disease Status COMPLETED Phase NA
NCT04594031 US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease Status WITHDRAWN Phase PHASE1
NCT04587661 Designing an Implementation Strategy for Delivering Routine Mental Health Screening and Treatment Status TERMINATED Phase NA
NCT04584528 Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease Status COMPLETED Phase NA
NCT04541875 Medication Adherence and Non-adherence in Adults With Rare Disease Status WITHDRAWN Phase N/A
NCT04514510 Fixed Dose Flavonoid Isoquercetin on Thrombo-Inflammatory Biomarkers in Subjects With Stable Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT04505969 A Study Aimed to Assess the Needs of Subjects With Sickle Cell Disease and Healthcare Professionals Managing Sickle Cell Disease Patients in Selected Nigerian Centres Status COMPLETED Phase N/A
NCT04484272 A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease Status COMPLETED Phase NA
NCT04476277 Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease Status COMPLETED Phase EARLY_PHASE1